ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 215 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $2,287,000 | -78.8% | 56,554 | -69.8% | 0.00% | -76.9% |
| Q2 2015 | $10,773,000 | +235.7% | 187,176 | +271.3% | 0.01% | +225.0% |
| Q1 2015 | $3,209,000 | +3.8% | 50,406 | +0.7% | 0.00% | 0.0% |
| Q4 2014 | $3,092,000 | +64.1% | 50,080 | +3.1% | 0.00% | +100.0% |
| Q3 2014 | $1,884,000 | -35.3% | 48,556 | -42.6% | 0.00% | -33.3% |
| Q2 2014 | $2,914,000 | -57.3% | 84,539 | -46.5% | 0.00% | -66.7% |
| Q1 2014 | $6,827,000 | +384.9% | 157,987 | +347.2% | 0.01% | +350.0% |
| Q4 2013 | $1,408,000 | -32.1% | 35,330 | -36.1% | 0.00% | -33.3% |
| Q3 2013 | $2,074,000 | +11.8% | 55,259 | -20.0% | 0.00% | 0.0% |
| Q2 2013 | $1,855,000 | – | 69,034 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|